CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice

Immunology Letters

Volumn 119, Issue 1-2, 2008, Pages 91-96

  Sumi, Tamaki ^a   Ishida, Waka ^a   Ojima, Ayako ^a   Kajisako, Minako ^a   Sakanishi, Tamami ^b   Yagita, Hideo ^b   Fukushima, Atsuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic conjunctivitis; CD27; CD70; Eosinophil

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CD27 ANTIBODY; CD70 ANTIBODY; CD70 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN; LIGAND; MONOCLONAL ANTIBODY; PLANT EXTRACT; RAGWEED EXTRACT;

ADOPTIVE TRANSFER; ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAGWEED POLLEN; SPLEEN; SPLEEN CELL;

ADOPTIVE TRANSFER; ALLERGENS; ALUM COMPOUNDS; AMBROSIA; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD27; ANTIGENS, CD70; CELL EXTRACTS; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; EOSINOPHILS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; VACCINATION;

EID: 47149104449     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.05.004     Document Type: Article

References (23)

1. Yoshida O., Yoshida H., Iwamoto H., Nishino K., Fukushima A., and Ueno H. Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 18 (1999) 117-124
2. Fukagawa K., Nakajima T., Tsubota K., Shimmura S., Saito H., and Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 103 (1999) 1220-1221
3. Messmer E.M., May C.A., Stefani F.H., Welge-Luessen U., and Kampik A. Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am J Ophthalmol 134 (2002) 816-821
4. Ozaki A., Seki Y., Fukushima A., and Kubo M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol 175 (2005) 5489-5497
5. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Taniguchi T., Liu F.T., et al. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice. Exp Eye Res 82 (2006) 210-218
6. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Mittler R.S., Yagita H., et al. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J Immunol 175 (2005) 4897-4903
7. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Yagita H., and Ueno H. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40. Invest Ophthalmol Vis Sci 47 (2006) 657-663
8. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Yagita H., and Ueno H. The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis. Biochem Biophys Res Commun 338 (2005) 1726-1731
9. Fukushima A., Yamaguchi T., Azuma M., Yagita H., and Ueno H. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol 90 (2006) 1040-1045
10. Sumi T., Fukushima A., Fukuda K., Kumagai N., Nishida T., Yagita H., et al. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis. Immunol Lett 108 (2007) 62-67
11. Polte T., Foell J., Werner C., Hoymann H.G., Braun A., Burdach S., et al. CD137-mediated immunotherapy for allergic asthma. J Clin Invest 116 (2006) 1025-1036
12. Polte T., Jagemann A., Foell J., Mittler R.S., and Hansen G. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8+ T cells. Clin Exp Allergy 37 (2007) 1374-1385
13. Jember A.G., Zuberi R., Liu F.T., and Croft M. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med 193 (2001) 387-392
14. Arestides R.S., He H., Westlake R.M., Chen A.I., Sharpe A.H., Perkins D.L., et al. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 32 (2002) 2874-2880
15. Hoshino A., Tanaka Y., Akiba H., Asakura Y., Mita Y., Sakurai T., et al. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 33 (2003) 861-869
16. Salek-Ardakani S., Song J., Halteman B.S., Jember A.G., Akiba H., Yagita H., et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 198 (2003) 315-324
17. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23 (2005) 23-68
18. Oshima H., Nakano H., Nohara C., Kobata T., Nakajima A., Jenkins N.A., et al. Characterization of murine CD70 by molecular cloning and mAb. Int Immunol 10 (1998) 517-526
19. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 109 (2000) 188-196
20. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15 (2001) 801-812
21. Hintzen R.Q., Lens S.M., Lammers K., Kuiper H., Beckmann M.P., and van Lier R.A. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 154 (1995) 2612-2623
22. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., and Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol (2000) 433-440
23. Hendriks J., Xiao Y., and Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 198 (2003) 1369-1380